Shenzhen Wingor Biotechnology Co., Ltd.
2 clinical trials · Sponsor
◉ Watch Shenzhen Wingor Biotechnology Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| Phase Ⅰ/Ⅱa Trial Evaluating Intravenous hUC-MSCs Injection for Safety, Tolerability and Efficacy in Patients With POI (NCT07775391) | Shenzhen Wingor Biotechnology Co., Ltd. | 2026-08-03 |
| A Phase IIa Clinical Trial to Evaluate the Efficacy and Safety of Intravenous Infusion of hUC-MSCs in Patients With AIS (NCT07084012) | Shenzhen Wingor Biotechnology Co., Ltd. | 2025-08-27 |
Track Shenzhen Wingor Biotechnology Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.